| Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ... The Lancet 372 (9651), 1733-1745, 2008 | 1724 | 2008 |
| The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan The Lancet 368 (9534), 531-536, 2006 | 700 | 2006 |
| Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work K Shannon, T Kerr, S Allinott, J Chettiar, J Shoveller, MW Tyndall Social science & medicine 66 (4), 911-921, 2008 | 657 | 2008 |
| Opioid use disorder J Strang, ND Volkow, L Degenhardt, M Hickman, K Johnson, GF Koob, ... Nature reviews Disease primers 6 (1), 3, 2020 | 587 | 2020 |
| Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic MW Tyndall, S Currie, P Spittal, K Li, E Wood, MV O'Shaughnessy, ... Aids 17 (6), 887-893, 2003 | 459 | 2003 |
| Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers K Shannon, T Kerr, SA Strathdee, J Shoveller, JS Montaner, MW Tyndall Bmj 339, 2009 | 443 | 2009 |
| Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy K Shannon, SA Strathdee, J Shoveller, M Rusch, T Kerr, MW Tyndall American journal of public health 99 (4), 659-665, 2009 | 393 | 2009 |
| Safer injection facility use and syringe sharing in injection drug users T Kerr, M Tyndall, K Li, J Montaner, E Wood The Lancet 366 (9482), 316-318, 2005 | 385 | 2005 |
| Occupational stigma as a primary barrier to health care for street-based sex workers in Canada L Lazarus, KN Deering, R Nabess, K Gibson, MW Tyndall, K Shannon Culture, health & sexuality 14 (2), 139-150, 2012 | 382 | 2012 |
| Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users T Kerr, N Fairbairn, M Tyndall, D Marsh, K Li, J Montaner, E Wood Drug and alcohol dependence 87 (1), 39-45, 2007 | 356 | 2007 |
| Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users E Wood, T Kerr, W Small, K Li, DC Marsh, JSG Montaner, MW Tyndall Cmaj 171 (7), 731-734, 2004 | 353 | 2004 |
| Hospital utilization and costs in a cohort of injection drug users A Palepu, MW Tyndall, H Leon, J Muller, MV O'Shaughnessy, ... Cmaj 165 (4), 415-420, 2001 | 352 | 2001 |
| Routes of administration for cannabis use–basic prevalence and related health outcomes: A scoping review and synthesis C Russell, S Rueda, R Room, M Tyndall, B Fischer International Journal of Drug Policy 52, 87-96, 2018 | 333 | 2018 |
| Mapping violence and policing as an environmental–structural barrier to health service and syringe availability among substance-using women in street-level sex work K Shannon, M Rusch, J Shoveller, D Alexson, K Gibson, MW Tyndall International Journal of Drug Policy 19 (2), 140-147, 2008 | 317 | 2008 |
| Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection DM Patrick, MW Tyndall, PGA Cornelisse, K Li, CH Sherlock, ML Rekart, ... Cmaj 165 (7), 889-895, 2001 | 295 | 2001 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 293 | 2005 |
| Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver PM Spittal, KJP Craib, E Wood, N Laliberté, K Li, MW Tyndall, ... Cmaj 166 (7), 894-899, 2002 | 291 | 2002 |
| Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? E Wood, MW Tyndall, PM Spittal, K Li, T Kerr, RS Hogg, JSG Montaner, ... Cmaj 165 (4), 405-410, 2001 | 285 | 2001 |
| Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users E Wood, JSG Montaner, B Yip, MW Tyndall, MT Schechter, ... Cmaj 169 (7), 656-661, 2003 | 277 | 2003 |
| Summary of findings from the evaluation of a pilot medically supervised safer injecting facility E Wood, MW Tyndall, JS Montaner, T Kerr Cmaj 175 (11), 1399-1404, 2006 | 276 | 2006 |
